Drug Information

Drug General Information
Drug ID
D08JHR
Former ID
DNC014125
Drug Name
N-(2-adamantyl)-N'-propylsulfamide
Drug Type
Small molecular drug
Indication Discovery agent Investigative [530389]
Formula
C13H24N2O2S
Canonical SMILES
CCCNS(=O)(=O)NC1C2CC3CC(C2)CC1C3
InChI
1S/C13H24N2O2S/c1-2-3-14-18(16,17)15-13-11-5-9-4-10(7-11)8-12(13)6-9/h9-15H,2-8H2,1H3
InChIKey
HVLBCVJJDOICDV-UHFFFAOYSA-N
PubChem Compound ID
16103199
Target and Pathway
Target(s) Cannabinoid receptor 1 Target Info Inhibitor [530389]
KEGG Pathway Rap1 signaling pathway
Neuroactive ligand-receptor interaction
Retrograde endocannabinoid signaling
PANTHER Pathway Endogenous cannabinoid signaling
Pathway Interaction Database N-cadherin signaling events
Reactome Class A/1 (Rhodopsin-like receptors)
G alpha (i) signalling events
WikiPathways GPCRs, Class A Rhodopsin-like
Small Ligand GPCRs
BDNF signaling pathway
GPCR ligand binding
GPCR downstream signaling
GPCRs, Other
References
Ref 530389Eur J Med Chem. 2009 Dec;44(12):4889-95. Epub 2009 Aug 12.Synthesis and pharmacological evaluation of sulfamide-based analogues of anandamide.
Ref 530389Eur J Med Chem. 2009 Dec;44(12):4889-95. Epub 2009 Aug 12.Synthesis and pharmacological evaluation of sulfamide-based analogues of anandamide.

If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Tang and Dr. Zhang.